- Home
- CPHI vs NVVE Comparison
CPHI vs NVVE Comparison
Compare CPHI & NVVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CPHI
- NVVE
- Stock Information
- Founded
- CPHI N/A
- NVVE 1996
- Country
- CPHI China
- NVVE United States
- Employees
- CPHI N/A
- NVVE N/A
- Industry
- CPHI Biotechnology: Pharmaceutical Preparations
- NVVE Oil Refining/Marketing
- Sector
- CPHI Health Care
- NVVE Energy
- Exchange
- CPHI Nasdaq
- NVVE Nasdaq
- Market Cap
- CPHI 4.5M
- NVVE 3.7M
- IPO Year
- CPHI N/A
- NVVE N/A
- Fundamental
- Price
- CPHI $1.65
- NVVE $0.91
- Analyst Decision
- CPHI
- NVVE
- Analyst Count
- CPHI 0
- NVVE 0
- Target Price
- CPHI N/A
- NVVE N/A
- AVG Volume (30 Days)
- CPHI 119.7K
- NVVE 113.1K
- Earning Date
- CPHI 05-14-2025
- NVVE 05-13-2025
- Dividend Yield
- CPHI N/A
- NVVE N/A
- EPS Growth
- CPHI N/A
- NVVE N/A
- EPS
- CPHI N/A
- NVVE N/A
- Revenue
- CPHI $4,528,929.00
- NVVE $5,286,229.00
- Revenue This Year
- CPHI N/A
- NVVE $892.33
- Revenue Next Year
- CPHI N/A
- NVVE N/A
- P/E Ratio
- CPHI N/A
- NVVE N/A
- Revenue Growth
- CPHI N/A
- NVVE N/A
- 52 Week Low
- CPHI $1.20
- NVVE $0.82
- 52 Week High
- CPHI $4.10
- NVVE $17.30
- Technical
- Relative Strength Index (RSI)
- CPHI 42.78
- NVVE 30.90
- Support Level
- CPHI $1.34
- NVVE $0.87
- Resistance Level
- CPHI $1.71
- NVVE $0.99
- Average True Range (ATR)
- CPHI 0.28
- NVVE 0.09
- MACD
- CPHI 0.00
- NVVE 0.03
- Stochastic Oscillator
- CPHI 37.38
- NVVE 31.03
About CPHI China Pharma Holdings Inc.
China Pharma Holding Inc is a drug manufacturing company. It is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in the People's Republic of China. The company mainly manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The product line of the company includes cefaclor dispersible tablets, clarithromycin granules, roxithromycin dispersible tablets, andrographolide tablets, ozagrel sodium for injection, gastrodin injection and others.
About NVVE Nuvve Holding Corp.
Nuvve Holding Corp is accelerating the electrification of transportation through its proprietary vehicle-to-grid (V2G) technology. It helps to support the integration of renewable energy sources, including solar and wind. Its Grid Integrated Vehicle (GIV) platform is refueling the next generation of electric vehicle fleets through bidirectional charging solutions. It has a geographic presence in the United States, the United Kingdom, and Denmark, of which it generates the majority of its revenue in the United States.